Etoposide injection Clinical Trials

4 actively recruiting trials

No change since May 2026

Also known as: VP-16213

Pipeline

Phase 1: 1Phase 2: 2Phase 3: 1

Top Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.1
Shanghai Hengrui Pharmaceutical Co., Ltd.1
BeBetter Med Inc1

Indications

Cancer4
Lung Cancer2
Relapsed/Refractory Diffuse Large B-cell Lymphoma1
Widespread Small Cell Lung Cancer1
Malignant Solid Tumors1

Other4 trials

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

Phase 2

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

Phase 1

SKB500 Combinations in Patients With Small Cell Lung Cancer

Phase 2

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.